Cape Talk, 25 May 2022 6:56 AM

Prof Rodney Dawson, MD University of Cape Town’s Lung Institute speaks to Refilwe Moloto about a new trial involving BTZ-043 (benzothiazinone DprE1 blocker), a novel TB drug candidate, which could see treatment time drastically reduced for a condition that claims hundreds of thousands of lives on the continent each year.

Listen to poscast: www.capetalk.co.za/podcasts/476/breakfast-with-refilwe-moloto/625808/africas-doctors-rallying-to-find-tb-cure-for-the-globe